Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues

To obtain a comprehensive view of the transcriptional programs in prostatic stromal cells of different histological/pathological origin, we profiled 18 adult human stromal cell cultures from normal transition zone (TZ), normal peripheral zone (PZ), benign prostatic hyperplasia (BPH), and prostate cancer (CA) using cDNA microarrays. A hierarchical clustering analysis of 714 named unique genes whose expression varied at least threefold from the overall mean abundance in at least three samples in all 18 samples demonstrated that cells of different origin displayed distinct gene expression profiles. Many of the differentially expressed genes are involved in biological processes known to be important in the development of prostatic diseases including cell proliferation and apoptosis, cell adhesion, and immune response. Significance Analysis of Microarrays (SAM) analysis identified genes that showed differential expression with statistical significance including 24 genes between cells from TZ versus BPH, 34 between BPH versus CA, and 101 between PZ versus CA. S100A4 and SULF1, the most up‐ and downregulated genes in BPH versus TZ, respectively, showed expression at the protein level consistent with microarray analysis. In addition, sulfatase assay showed that BPH cells have lower SULF1 activity compared to TZ cells. Quantitative real‐time polymerase chain reaction (qRT‐PCR) analysis confirmed differential expression of ENPP2/autotoxin and six other genes between PZ versus CA, as well as differential expression of six genes between BPH versus CA. Our results support the hypothesis that prostatic stromal cells of different origin have unique transcriptional programs and point towards genes involved in actions of stromal cells in BPH and CA. J. Cell. Physiol. 210: 111–121, 2007. © 2006 Wiley‐Liss, Inc.

[1]  P. Nelson,et al.  Predicting prostate cancer behavior using transcript profiles. , 2004, The Journal of urology.

[2]  C. Ball,et al.  The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. , 2004, The American journal of pathology.

[3]  M. Bittner,et al.  Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. , 2001, Cancer research.

[4]  J. Eun,et al.  Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate. , 2005, Biochemical and Biophysical Research Communications - BBRC.

[5]  S. Cramer,et al.  A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. , 2005, Endocrinology.

[6]  David I. Smith,et al.  Loss of HSulf-1 Up-regulates Heparin-binding Growth Factor Signaling in Cancer* , 2003, Journal of Biological Chemistry.

[7]  David I. Smith,et al.  hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. , 2004, Gastroenterology.

[8]  D. Peehl,et al.  Molecular and cellular pathogenesis of benign prostatic hyperplasia. , 2004, The Journal of urology.

[9]  T. Stamey,et al.  Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer. , 2005, Cancer letters.

[10]  R. Peterson,et al.  Sonic hedgehog signaling regulates the expression of insulin‐like growth factor binding protein‐6 during fetal prostate development , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[11]  O. Franco,et al.  Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. , 2005, Cancer research.

[12]  B. Neubauer,et al.  Epithelial-mesenchymal interactions in prostatic development. II. Biochemical observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder , 1983, The Journal of cell biology.

[13]  G. Dhoot,et al.  Regulation of vascular smooth muscle cell proliferation, migration and death by heparan sulfate 6‐O‐endosulfatase1 , 2005, FEBS letters.

[14]  B. Giepmans,et al.  The ins and outs of lysophosphatidic acid signaling , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[15]  D. Peehl,et al.  Expression of transforming growth factor‐beta 1 and growth in soft agar differentiate prostate carcinoma‐associated fibroblasts from normal prostate fibroblasts , 2004, International journal of cancer.

[16]  G. Ayala,et al.  Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. , 2002, Cancer research.

[17]  G. Ayala,et al.  Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  P. Scardino,et al.  Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. McNeal,et al.  Pathology of benign prostatic hyperplasia. Insight into etiology. , 1990, The Urologic clinics of North America.

[21]  Y. S. Kim,et al.  Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. , 2001, Cancer research.

[22]  T. Stamey,et al.  Genetic profiling of Gleason grade 4/5 prostate cancer: which is the best prostatic control tissue? , 2003, The Journal of urology.

[23]  A. Fischer,et al.  Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  L. Chung,et al.  Stromal‐epithelial interactions: II. Regulation of prostatic growth by embryonic urogenital sinus mesenchyme , 1983, The Prostate.

[25]  G. Mills,et al.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.

[26]  G. Cunha,et al.  Induction of nuclear androgen-binding sites in epithelium of the embryonic urinary bladder by mesenchyme of the urogenital sinus of embryonic mice. , 1980, Endocrinology.

[27]  O. Cussenot,et al.  Molecular profiling of benign prostatic hyperplasia using a large scale real-time reverse transcriptase-polymerase chain reaction approach. , 2004, The Journal of urology.

[28]  S. J. Higgins,et al.  The endocrinology and developmental biology of the prostate. , 1987, Endocrine reviews.

[29]  J. McNeal.  Origin and evolution of benign prostatic enlargement. , 1978, Investigative urology.

[30]  J. Brooks,et al.  Molecular targets of doxazosin in human prostatic stromal cells , 2005, The Prostate.

[31]  M. Becich,et al.  The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia. , 1992, The Journal of urology.

[32]  G. Cunha,et al.  Heterospecific induction of prostatic development in tissue recombinants prepared with mouse, rat, rabbit and human tissues. , 1983, Differentiation; research in biological diversity.

[33]  D. S. Coffey,et al.  Etiology and disease process of benign prostatic hyperplasia , 1989, The Prostate. Supplement.

[34]  David Botstein,et al.  The Stanford Microarray Database , 2001, Nucleic Acids Res..

[35]  James D Brooks,et al.  Microarray analysis in prostate cancer research , 2002, Current opinion in urology.

[36]  Ash A. Alizadeh,et al.  Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.

[37]  S. Hayward,et al.  Malignant transformation in a nontumorigenic human prostatic epithelial cell line. , 2001, Cancer research.

[38]  S. Hayward,et al.  Role of stroma in carcinogenesis of the prostate. , 2002, Differentiation; research in biological diversity.

[39]  W. Bushman,et al.  Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation. , 2002, Developmental biology.

[40]  R. Sellers,et al.  Cultured stromal cells: An in vitro model of prostatic mesenchymal biology , 2000, The Prostate.

[41]  D. Kessler,et al.  QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Strutz,et al.  Identification and characterization of a fibroblast marker: FSP1 , 1995, The Journal of cell biology.

[43]  D. Brindley.  Lipid phosphate phosphatases and related proteins: Signaling functions in development, cell division, and cancer , 2004, Journal of cellular biochemistry.

[44]  P. Neiman,et al.  Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun , 2004, Oncogene.

[45]  M. S. Condon.  The role of the stromal microenvironment in prostate cancer. , 2005, Seminars in cancer biology.

[46]  L. Chung,et al.  Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. , 2005, The Journal of urology.

[47]  S. Hayward,et al.  Role of the stromal microenvironment in carcinogenesis of the prostate , 2003, International journal of cancer.

[48]  Masahiko Watanabe,et al.  Lysophosphatidic Acid and Autotaxin Stimulate Cell Motility of Neoplastic and Non-neoplastic Cells through LPA1* , 2004, Journal of Biological Chemistry.

[49]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[50]  David I. Smith,et al.  HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma , 2004, Oncogene.

[51]  G. Ayala,et al.  Reactive stroma in prostate cancer progression. , 2001, The Journal of urology.

[52]  F. Strutz,et al.  Identification and Characterization of a Fibroblast Marker : FSP 1 , 2002 .

[53]  Y. Okada.  Volume expansion-sensing outward-rectifier Cl- channel: fresh start to the molecular identity and volume sensor. , 1997, The American journal of physiology.

[54]  R. Kalluri,et al.  Early role of Fsp1 in epithelial-mesenchymal transformation. , 1997, American journal of physiology. Renal physiology.